Literature DB >> 12163693

Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology.

S Jill James1, Stepan Melnyk, Marta Pogribna, Igor P Pogribny, Marie A Caudill.   

Abstract

Chronic nutritional deficiencies in folate, choline, methionine, vitamin B-6 and/or vitamin B-12 can perturb the complex regulatory network that maintains normal one-carbon metabolism and homocysteine homeostasis. Genetic polymorphisms in these pathways can act synergistically with nutritional deficiencies to accelerate metabolic pathology associated with occlusive heart disease, birth defects and dementia. A major unanswered question is whether homocysteine is causally involved in disease pathogenesis or whether homocysteinemia is simply a passive and indirect indicator of a more complex mechanism. S-Adenosylmethionine and S-adenosylhomocysteine (SAH), as the substrate and product of methyltransferase reactions, are important metabolic indicators of cellular methylation status. Chronic elevation in homocysteine levels results in parallel increases in intracellular SAH and potent product inhibition of DNA methyltransferases. SAH-mediated DNA hypomethylation and associated alterations in gene expression and chromatin structure may provide new hypotheses for pathogenesis of diseases related to homocysteinemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163693     DOI: 10.1093/jn/132.8.2361S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  90 in total

1.  Impact of folic acid intake during pregnancy on genomic imprinting of IGF2/H19 and 1-carbon metabolism.

Authors:  Aggeliki Tserga; Alexandra M Binder; Karin B Michels
Journal:  FASEB J       Date:  2017-08-04       Impact factor: 5.191

Review 2.  Folate and Alzheimer: when time matters.

Authors:  Margareta Hinterberger; Peter Fischer
Journal:  J Neural Transm (Vienna)       Date:  2012-05-25       Impact factor: 3.575

Review 3.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

4.  A simple rapid immunoassay for S-adenosylhomocysteine in plasma.

Authors:  Antonieta Capdevila; Raymond F Burk; Joshua Freedman; Frank Frantzen; Ingrid Alfheim; Conrad Wagner
Journal:  J Nutr Biochem       Date:  2007-05-16       Impact factor: 6.048

Review 5.  Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.

Authors:  Cynthia M Carlsson
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 6.  Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale?

Authors:  Graham C Burdge; Karen A Lillycrop; Alan A Jackson
Journal:  Br J Nutr       Date:  2008-12-12       Impact factor: 3.718

7.  Relationship of impairment induced by intracellular S-adenosylhomocysteine accumulation with DNA methylation in human umbilical vein endothelial cells treated with 3-deazaadenosine.

Authors:  Xiaoping Yu; Wenhua Ling; Mantian Mi
Journal:  Int J Exp Pathol       Date:  2009-12       Impact factor: 1.925

8.  Early Manifestations of Brain Aging in Mice Due to Low Dietary Folate and Mild MTHFR Deficiency.

Authors:  Renata H Bahous; Marta Cosín-Tomás; Liyuan Deng; Daniel Leclerc; Olga Malysheva; Ming-Kai Ho; Mercè Pallàs; Perla Kaliman; Barry J Bedell; Marie A Caudill; Rima Rozen
Journal:  Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.590

9.  Hyperhomocysteinemia during aortic aneurysm, a plausible role of epigenetics.

Authors:  Nithya Narayanan; Neetu Tyagi; Amy Shah; Sebastian Pagni; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-03-08

10.  Perinatal folate-related exposures and risk of psychotic symptoms in the ALSPAC birth cohort.

Authors:  B Glaser; A E Ades; S Lewis; P Emmet; G Lewis; G Davey Smith; S Zammit
Journal:  Schizophr Res       Date:  2010-04-24       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.